Methylglyoxal Produced by Amyloid-β Peptide-Induced Nitrotyrosination of Triosephosphate Isomerase Triggers Neuronal Death in Alzheimer's Disease

被引:36
|
作者
Tajes, Marta [1 ]
Eraso-Pichot, Abel [1 ]
Rubio-Moscardo, Fanny [1 ]
Guivernau, Biuse [1 ]
Ramos-Fernandez, Eva [1 ]
Bosch-Morato, Monica [1 ]
Xavier Guix, Francesc [1 ]
Clarimon, Jordi [2 ]
Pietro Miscione, Gian [3 ,4 ]
Boada, Merce [5 ,6 ]
Gil-Gomez, Gabriel [7 ]
Suzuki, Toshiharu [8 ]
Molina, Henrik [9 ,10 ]
Villa-Freixa, Jordi [3 ,11 ]
Vicente, Ruben [1 ]
Munoz, Francisco J. [1 ]
机构
[1] Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Ciencies Expt & Salut DCEXS, Barcelona 08003, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Neurol, Alzheimer Lab, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain
[3] IMIM UPF, DCEXS, Res Program Biomed Informat, Computat Biochem & Biophys Lab, Barcelona, Spain
[4] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy
[5] Fundaci ACE Inst Catala Neurociencies Aplicades, Memory Clin, Barcelona, Spain
[6] Univ Autonoma Barcelona VHIR UAB, Hosp Univ Vall dHebron Inst Recerca, Dept Neurol, Barcelona, Spain
[7] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain
[8] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido, Japan
[9] UPF, DCEXS, Prote Unit, Barcelona, Spain
[10] CRG, Barcelona, Spain
[11] Univ Vic, Escola Politecn Super, Girona, Spain
关键词
Alzheimer's disease; amyloid; apoptosis; methylglyoxal; 3-nitrotyrosine; triose-phosphate isomerase; TRIOSE PHOSPHATE ISOMERASE; OXIDATIVE STRESS; NITRIC-OXIDE; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; TAU-PROTEIN; NEUROTOXICITY; GLYCATION; BRAIN; PEROXYNITRITE;
D O I
10.3233/JAD-131685
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Amyloid-beta peptide (A beta) aggregates induce nitro-oxidative stress, contributing to the characteristic neurodegeneration found in Alzheimer's disease (AD). One of the most strongly nitrotyrosinated proteins in AD is the triosephosphate isomerase (TPI) enzyme which regulates glycolytic flow, and its efficiency decreased when it is nitrotyrosinated. The main aims of this study were to analyze the impact of TPI nitrotyrosination on cell viability and to identify the mechanism behind this effect. In human neuroblastoma cells (SH-SY5Y), we evaluated the effects of A beta(42) oligomers on TPI nitrotyrosination. We found an increased production of methylglyoxal (MG), a toxic byproduct of the inefficient nitro-TPI function. The proapoptotic effects of A beta(42) oligomers, such as decreasing the protective Bcl2 and increasing the proapoptotic caspase-3 and Bax, were prevented with a MG chelator. Moreover, we used a double mutant TPI (Y165F and Y209F) to mimic nitrosative modifications due to A beta action. Neuroblastoma cells transfected with the double mutant TPI consistently triggered MG production and a decrease in cell viability due to apoptotic mechanisms. Our data show for the first time that MG is playing a key role in the neuronal death induced by A beta oligomers. This occurs because of TPI nitrotyrosination, which affects both tyrosines associated with the catalytic center.
引用
收藏
页码:273 / 288
页数:16
相关论文
共 50 条
  • [31] Heme binding to Amyloid-β peptide:: Mechanistic role in Alzheimer's disease
    Atamna, Hani
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2006, 10 (2-3) : 255 - 266
  • [32] Cellular prion protein and Alzheimer disease Link to oligomeric amyloid-β and neuronal cell death
    Kudo, Wataru
    Petersen, Robert B.
    Lee, Hyoung-gon
    [J]. PRION, 2013, 7 (02) : 114 - 116
  • [33] The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's disease
    Zhao, Jiuhong
    Xu, Na
    Yang, Xiaotong
    Ling, Guixia
    Zhang, Peng
    [J]. COLLOID AND INTERFACE SCIENCE COMMUNICATIONS, 2022, 46
  • [34] Is amyloid-β-peptide immunization clinically effective in patients with Alzheimer's disease?
    Wisniewski, T
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2005, 1 (02): : 84 - 85
  • [35] The amyloid-β peptide in Alzheimer's disease: molecular interactions and structure conversions
    Graslund, Astrid
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [36] Is amyloid-β-peptide immunization clinically effective in patients with Alzheimer's disease?
    Thomas Wisniewski
    [J]. Nature Clinical Practice Neurology, 2005, 1 : 84 - 85
  • [37] Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer's disease
    Gomes, Luiza M. F.
    Bataglioli, Janaina C.
    Storr, Tim
    [J]. COORDINATION CHEMISTRY REVIEWS, 2020, 412
  • [38] CD45 Deficiency Drives Amyloid-β Peptide Oligomers and Neuronal Loss in Alzheimer's Disease Mice
    Zhu, Yuyan
    Hou, Huayan
    Rezai-Zadeh, Kavon
    Giunta, Brian
    Ruscin, Amanda
    Gemma, Carmelina
    Jin, JingJi
    Dragicevic, Natasa
    Bradshaw, Patrick
    Rasool, Suhail
    Glabe, Charles G.
    Ehrhart, Jared
    Bickford, Paula
    Mori, Takashi
    Obregon, Demian
    Town, Terrence
    Tan, Jun
    [J]. JOURNAL OF NEUROSCIENCE, 2011, 31 (04): : 1355 - 1365
  • [39] Cell degeneration induced by amyloid-β peptidesImplications for alzheimer’s disease
    Cláudia Pereira
    Elisabete Ferreiro
    Sandra Morais Cardoso
    Catarina Resende de Oliveira
    [J]. Journal of Molecular Neuroscience, 2004, 23 : 97 - 104
  • [40] Amyloid-β-Induced Amyloid-β Secretion: A Possible Feed-Forward Mechanism in Alzheimer's Disease
    Marsden, Ian T.
    Minamide, Laurie S.
    Bamburg, James R.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 (04) : 681 - 691